
About FBB Biomed
FBB Biomed is a Healthcare company based in Coralville (United States) founded in 2020. In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. FBB Biomed has raised $401 thousand across 2 funding rounds. Its chief executive, as recorded, is Howard Urnovitz. FBB Biomed offers products and services including FBB Test and Research Blood Tests. Its focus areas include Life Sciences, Neurology, In-Vitro Diagnostics and Neurodevelopmental Disorders. Its legal entity is FBB Biomed, Inc. Its competitors include DermTech, NeuMoDx and Kryptos Biotechnologies; 3 of its 3 listed competitors have raised funding.
Company details
FBB Biomed was founded in 2020 and is based in Coralville, United States, within the biotechnology sector focused on diagnostics. In-vitro tests for COVID-19 and neurological conditions are developed through a process where finger-stick blood samples are collected from patients, RNA is extracted, and analysis is conducted via qPCR. Clinical reports are then produced and interpreted. Data from blood samples of three relapsing-remitting multiple sclerosis patients have been incorporated.
- Headquarters Coralville, United States
- SectorsHealthcare
- Website fbbbio.com
- Social LinkedIn X YouTube
- Legal Name Fbb Biomed, Inc.
- Total Equity Funding$401K (USD)
in 2 rounds
- Latest Funding Round$326K (USD), Seed
Aug 2020
Products & Services of FBB Biomed
FBB Biomed offers a comprehensive portfolio of products and services, including FBB Test and Research Blood Tests.
Noninvasive test to detect genes linked to autoimmune diseases for research.
Tools for measuring external influences on neurologic health in studies.
Apps and channels of FBB Biomed
its YouTube channel FBB Biomed has 53 subscribers and 27 videos.
Videos from FBB Biomed
The most watched videos on FBB Biomed's YouTube channel, FBB Biomed (53 subscribers). Click a video to play it here.
More on FBB Biomed.
Funding Insights of FBB Biomed
FBB Biomed has successfully raised a total of $401K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $326 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $401,000
- Total Rounds 2
- Last Round Seed β $326,000
- First Round $75,000
(Jan 2020)
All 2 funding rounds of FBB Biomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $326,000 | Seed | β | β | β |
| Jan 2020 | $75,000 | Seed | β | β | β |
People of FBB Biomed
9 people are tracked at FBB Biomed (2 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Howard Urnovitz | CEO | Leadership |
Steven Urnovitz | Co-founder, COO | Leadership |
Heinz Haenel | Product GTM Expert | Team |
Shauna Turner | Biotech Industry Expert | Team |
Lior Nuchi | Tech Industry Lawyer | Team |
Timothy Dodd | Insurance Industry Expert | Team |
Heinz Dr. Hänel | Senior Berater | Team |
Michael S. Chimenti | Machine Learning & Bioinformatics Consultant | Team |
Lindsey Kaschmitter | Research Analyst | Team |
Complete people profiles for FBB Biomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FBB Biomed
3 dated milestones of FBB Biomed, from founding to its latest funding, stage changes and deals.
- Founded FBB Biomed is founded.
- Funding First funding round of $75K.
- Funding Latest funding round, Seed, of $326K.
Competitors of FBB Biomed
FBB Biomed has 3 listed competitors in our database, 3 of them funded. They include DermTech, NeuMoDx and Kryptos Biotechnologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| kryptosbio.com | 2017 | Hayward, United States | $12.7M | Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology. |
Detailed competitors of FBB Biomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as FBB Biomed (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fbb Biomed
Complete news archive for FBB Biomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FBB Biomed
FBB Biomed was founded in 2020.
FBB Biomed is headquartered in Coralville, United States. It is registered at Coralville, Iowa, United States.
Howard Urnovitz is the CEO of FBB Biomed, as recorded in our data.
FBB Biomed is a funded company, having raised a total of $401K across 2 funding rounds to date. The company's 1st funding round was a Seed of $75K, raised on Jan 2020.
FBB Biomed was founded in 2020 and is based in Coralville, United States, within the biotechnology sector focused on diagnostics. In-vitro tests for COVID-19 and neurological conditions are developed through a process where finger-stick blood samples are collected from patients, RNA is extracted, and analysis is conducted via qPCR. Clinical reports are then produced and interpreted. Data from blood samples of three relapsing-remitting multiple sclerosis patients have been incorporated.
FBB Biomed's top competitors include DermTech, NeuMoDx and Kryptos Biotechnologies.
FBB Biomed offers FBB Test and Research Blood Tests.
FBB Biomed operates through Fbb Biomed, Inc..
